Usage of nanoparticles with their potential toxicity assessment and regulatory guidelines

In recent times engineered nanoparticles have been receiving much attention from researchers due to their extensive use in a variety of chemical, biological, and industrial areas. Their physiochemical properties have led to a number of uses in commercial products. Considering their broad applications, with increasing human contact the risks of exposure are also increasing. In vivo toxicity experiments involving administering nanoparticles to living organisms have shown their adverse effects on organ development and reproduction. Nanoparticles can be considerably more toxic than the large-sized particles since they can move relatively freely compared to bulkier molecules. Henceforth, it is our duty to assess the harmful health consequences associated with human exposure to nanoparticles in order to improve safe production and use. We will review the current applications of nanoparticles, and issues related to their toxicity. We will focus on safety regulations, risk assessment and regulatory guidelines of nanoparticles. The validation and standardization of nanotoxicity tests will further promote safe applications of nanotechnology in our daily lives.

[1]  Winston Soboyejo,et al.  For the surgeon: an introduction to nanotechnology. , 2008, Journal of surgical education.

[2]  F. Iemma,et al.  Silica-Based Mesoporous Materials as Drug Delivery System for Methotrexate Release , 2007, Drug delivery.

[3]  Minghua Zhang,et al.  Nanoscience and nanotechnology: evolving definitions and growing footprint on the scientific landscape. , 2011, Small.

[4]  Michael J Sailor,et al.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.

[5]  Tomas S Jonaitis,et al.  An appraisal of the published literature on the safety and toxicity of food-related nanomaterials , 2011, Critical reviews in toxicology.

[6]  L. Lou,et al.  Synthesis and anticancer activity of lipophilic platinum(II) complexes of 3,5-diisopropylsalicylate. , 2008, European journal of medicinal chemistry.

[7]  Raoul Kopelman,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.

[8]  J. Rishpon,et al.  Electrochemical lab on a chip for high-throughput analysis of anticancer drugs efficiency. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[9]  C. Kuan,et al.  Nanotech: Propensity in Foods and Bioactives , 2012, Critical reviews in food science and nutrition.

[10]  María Vallet-Regí,et al.  Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. , 2006, Chemistry.

[11]  G. Oberdörster,et al.  Lung particle overload: implications for occupational exposures to particles. , 1995, Regulatory toxicology and pharmacology : RTP.

[12]  Li Li,et al.  Repair of enamel by using hydroxyapatite nanoparticles as the building blocks , 2008 .

[13]  Sha Jin,et al.  Nanoparticle-mediated gene delivery. , 2009, Methods in molecular biology.

[14]  Robert Langer,et al.  Tissue-specific gene delivery via nanoparticle coating. , 2010, Biomaterials.

[15]  James M Tour,et al.  Is nanotechnology too broad to practise? , 2010, Nature nanotechnology.

[16]  M. Hande,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.

[17]  S. Pratsinis,et al.  Synthesis, characterization, and bioavailability in rats of ferric phosphate nanoparticles. , 2007, The Journal of nutrition.

[18]  G. Oberdörster,et al.  Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology , 2010, Journal of internal medicine.

[19]  Peter Wipf,et al.  Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.

[20]  M. Vallet‐Regí Ordered Mesoporous Materials in the Context of Drug Delivery Systems and Bone Tissue Engineering , 2006 .

[21]  Sungho Jin,et al.  Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.

[22]  Thomas Kuhlbusch,et al.  Particle and Fibre Toxicology BioMed Central Review The potential risks of nanomaterials: a review carried out for ECETOC , 2006 .

[23]  J. Dobson,et al.  Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery , 2006, Gene Therapy.

[24]  Marike Kolossa-Gehring,et al.  The carcinogenic potential of nanomaterials, their release from products and options for regulating them. , 2011, International journal of hygiene and environmental health.

[25]  Tal Dvir,et al.  Nanowired three dimensional cardiac patches , 2011, Nature nanotechnology.

[26]  Shuming Nie,et al.  Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. , 2009, Current drug discovery technologies.

[27]  Ji-Xin Cheng,et al.  Hyperthermic effects of gold nanorods on tumor cells. , 2007, Nanomedicine.

[28]  Meyoung-kon Kim,et al.  A safety assessment of phototoxicity and sensitization of SiO2 nanoparticles , 2011, Molecular & Cellular Toxicology.

[29]  A. Boxall,et al.  Detection and characterization of engineered nanoparticles in food and the environment , 2008, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[30]  J. Carter,et al.  ANTIOXIDANT DEFENSE MECHANISMS AND THE TOXICITY OF FIBROUS AND NONFIBROUS PARTICLES , 2002, Inhalation toxicology.

[31]  J. Everitt,et al.  Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  María Vallet-Regí,et al.  Mesoporous materials for drug delivery. , 2007, Angewandte Chemie.

[33]  Michael S. Goldberg,et al.  Nanostructured materials for applications in drug delivery and tissue engineering , 2007, Journal of biomaterials science. Polymer edition.

[34]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[35]  E. Hood Nanotechnology: Looking As We Leap , 2004, Environmental health perspectives.

[36]  H. Raiffa,et al.  Applied Statistical Decision Theory. , 1961 .

[37]  Helinor J Johnston,et al.  Air Pollution, Ultrafine and Nanoparticle Toxicology: Cellular and Molecular Interactions , 2007, IEEE Transactions on NanoBioscience.

[38]  Andrew D. Maynard,et al.  Don't define nanomaterials , 2011, Nature.

[39]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[40]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[41]  John A Tomenson,et al.  Titanium dioxide: inhalation toxicology and epidemiology. , 2005, The Annals of occupational hygiene.

[42]  N. Kim,et al.  Silver-particle-based surface-enhanced resonance Raman scattering spectroscopy for biomolecular sensing and recognition , 2007, Analytical and bioanalytical chemistry.